MarketLens
Sign Up

What Does the Angelini Pharma Acquisition Mean for Catalyst Pharmaceuticals (CPRX) Shareholders

6 months ago
SHARE THIS ON:

What Does the Angelini Pharma Acquisition Mean for Catalyst Pharmaceuticals (CPRX) Shareholders

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•2 months ago

IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?

LB Pharmaceuticals shares have more than tripled since its IPO in under a year, as investors track its neuropsychiatric disorder programs. The rally could attract takeover interest if clinical data re...
Stock News•4 months ago

Catalyst Pharmaceuticals Stockholders Clear Angelini Pharma Merger

Catalyst Pharmaceuticals (CPRX) stockholders approved the merger with Angelini Pharma S.p.A. at a virtual special meeting on July 8, clearing a key regulatory hurdle.
Stock News•4 months ago

CRNX Stock Alert: Halper Sadeh LLC is Investigating Whether Crinetics Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

Crinetics Pharmaceuticals (CRNX) is under investigation by Halper Sadeh LLC over its $85/share cash sale to Vertex, focusing on whether shareholders are receiving fair value.

Breaking News

View All →

Top Headlines

View More →
Press Release•34 minutes ago

Advanced Micro Devices, Inc. Investigated on Behalf of Investors with $100,000 or More in Losses - Contact the DJS Law Group to Discuss Your Rights – AMD

Stock News•1 hour ago

Methuselah Advisors Issues Open Letter to the Board of Directors of NVIDIA Corporation

Stock News•1 hour ago

Stock Market Today, Nov. 20: Amazon Shares Slide on AI and Mega-Cap Tech Sell-Off

Stock News•1 hour ago

AMD Investors Have Opportunity to Join Advanced Micro Devices, Inc. Fraud Investigation with SBS Law

Stock News•1 hour ago

Nvidia Plunges as SEC Probe Deepens AI Market Selloff | Closing Bell